Literature DB >> 10931021

Randomized clinical trial of laparoscopic versus open fundoplication: blind evaluation of recovery and discharge period.

G Nilsson1, S Larsson, F Johnsson.   

Abstract

BACKGROUND: There is a widespread belief that introduction of the laparoscopic technique in antireflux surgery has led to easier postoperative recovery. To test this hypothesis a prospective randomized clinical trial with blind evaluation was conducted between laparoscopic and open fundoplication.
METHODS: Sixty patients with gastro-oesophageal reflux disease were randomized to open or laparoscopic 360 degrees fundoplication. The type of operation was unknown to the patient and the evaluating nurses after operation.
RESULTS: The operating time was longer in the laparoscopy group, median 148 versus 109 min (P < 0.0001). The need for analgesics was less in the laparoscopically operated patients, 33.9 versus 67.5 mg morphine per total hospital stay (P < 0.001). There was no significant difference in postoperative nausea and vomiting. On the first day after operation patients in the laparoscopy group had better respiratory function: forced vital capacity 3.2 versus 2. 2 litres (P = 0.004) and forced expiratory volume 2.6 versus 2.0 litres (P = 0.008). Postoperative hospital stay was shorter in the laparoscopic group, median (range) 3 (2-6) versus 3 (2-10) days (P = 0.021). No difference was found in the duration of sick leave.
CONCLUSION: Laparoscopic fundoplication was associated with a longer operating time, better respiratory function, less need for analgesics and a shorter hospital stay, while no reduction in the duration of postoperative sick leave was found compared with open surgery.

Entities:  

Mesh:

Year:  2000        PMID: 10931021     DOI: 10.1046/j.1365-2168.2000.01471.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  29 in total

1.  Computer-enhanced vs. standard laparoscopic antireflux surgery.

Authors:  W Scott Melvin; Bradley J Needleman; Kevin R Krause; Carol Schneider; E Christopher Ellison
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

2.  [Laparoscopic fundoplication. Indications and results].

Authors:  K H Fuchs; H Feussner
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

3.  Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Protagonist.

Authors:  L Lundell
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  SAGES Appropriateness Conference: a summary.

Authors:  R E Glasgow; A Fingerhut; J Hunter
Journal:  Surg Endosc       Date:  2003-09-29       Impact factor: 4.584

5.  Manual robot assisted endoscopic suturing: time-action analysis in an experimental model.

Authors:  J P Ruurda; I A M J Broeders; B Pulles; F M Kappelhof; C van der Werken
Journal:  Surg Endosc       Date:  2004-05-28       Impact factor: 4.584

Review 6.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 7.  Minimally invasive surgery.

Authors:  B Jaffray
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

8.  Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication: a randomized trial.

Authors:  Werner A Draaisma; Hilda G Rijnhart-de Jong; Ivo A M J Broeders; Andre J P M Smout; Edgar J B Furnee; Hein G Gooszen
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

9.  Comparison of long-term outcome of laparoscopic and conventional nissen fundoplication: a prospective randomized study with an 11-year follow-up.

Authors:  Paulina T P Salminen; Heikki I Hiekkanen; Arto P T Rantala; Jari T Ovaska
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

Review 10.  Evidence-based appraisal of antireflux fundoplication.

Authors:  Marco Catarci; Paolo Gentileschi; Claudio Papi; Alessandro Carrara; Renato Marrese; Achille Lucio Gaspari; Giovanni Battista Grassi
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.